Harvey Nash Group plc Q&A with Zeus Capital (LON:HVN)
15 September 2017
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) stands out as a significant player in the biotechnology sector, focusing on developing innovative therapies for central nervous system (CNS)..
Altimmune, Inc. (NASDAQ: ALT), a promising player in the biotechnology sector, has caught the attention of investors with a striking potential upside of 497.04%. Based in..
Zenas BioPharma, Inc. (ZBIO), a clinical-stage biotechnology company, has captured the attention of investors with its transformative approach to immunology-based therapies. Headquartered in Waltham, Massachusetts, Zenas..
Tyra Biosciences, Inc. (NASDAQ: TYRA), a burgeoning name in the biotechnology sector, is making significant strides in the development of precision medicines, primarily targeting fibroblast growth..
Stoke Therapeutics, Inc. (NASDAQ: STOK) stands prominently in the biotech sector, drawing significant attention from investors with its innovative approach to addressing severe genetic diseases. Specializing..
Enhabit, Inc. (EHAB), a key player in the healthcare sector, focuses on providing home health and hospice services across the United States. With a market capitalization..
Weave Communications, Inc. (NASDAQ: WEAV) is making waves in the healthcare technology sector with its robust AI-powered communication platform tailored for small and medium-sized healthcare businesses...
Nuvation Bio Inc. (NASDAQ: NUVB) is capturing attention in the biotechnology sector with a notable potential upside of 156.41%, as indicated by its average target price..
Community Health Systems, Inc. (NYSE: CYH), a key player in the healthcare sector, operates primarily in the medical care facilities industry. With a market capitalization of..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector specializing in the development of pain management medications, is currently capturing the attention of..
Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing the attention of investors with its promising potential in the biotechnology sector. As a clinical-stage biopharmaceutical company, Trevi Therapeutics..
For investors seeking opportunities in the biotechnology sector, Niagen Bioscience, Inc. (NASDAQ: NAGE) presents an intriguing proposition. With its focus on healthy aging products and a..
Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative oncolytic immunotherapy product candidates. As the company..
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a notable player in the healthcare sector, specifically within the biotechnology industry. Headquartered in San Diego, California, Maravai..
Investors with a penchant for high-risk, high-reward opportunities may find Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) an intriguing prospect. The biopharmaceutical company, with a market capitalization of..
Investors looking for compelling opportunities in the healthcare sector should turn their attention to iRadimed Corporation (NASDAQ: IRMD), a leading developer and manufacturer of MRI-compatible medical..
GH Research PLC (NASDAQ: GHRS), a promising player in the biopharmaceutical sector, is garnering significant investor attention due to its innovative approach to treating mental health..
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) stands as a compelling investment opportunity in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. Headquartered in..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a beacon in the biotechnology sector, is drawing significant attention from investors due to its ambitious pipeline and promising market positioning...
Upstream Bio, Inc. (NASDAQ: UPB) is gaining attention in the investment community with its remarkable potential upside of 384.94%, according to recent analyst ratings. As a..
